Cadrenal Therapeutics Inc

CUSIP 127636207COM NEWCVKDQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

23.6%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

5 filings · latest Feb 12, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 12, 2025	Havlickova 648 A.S.	13G/A	4.4%	78.3K	SEC
2	Jan 29, 2025	Quang X. Pham	13D	23.6%	—	SEC
3	Jan 15, 2025	John Raymond Murphy	13G/A	3.0%	53.2K	SEC
4	Nov 14, 2024	Armistice Capital, LLC	13G/A	5.0%	78.6K	SEC
5	Oct 4, 2024	Havlickova 648 A.S.	13G	6.2%	66.3K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Geode Capital Management, LLC	21.6K	$110.7K
2	Jpmorgan Chase & Co	7.5K	$31.9K
3	Blackrock, Inc.	5.5K	$28.1K
4	Tower Research Capital LLC (Trc)	393	$2.0K
5	Osaic Holdings, Inc.	300	$1.5K
6	Destiny Wealth Partners, LLC	200	$1.0K
7	Rockefeller Capital Management L.P.	150	$768
8	Morgan Stanley	100	$512
9	Wells Fargo & Company/Mn	99	$507
10	Archer Investment Corp	35	$179